drugset / Trial / NCT03289650
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
RandomizedParallel-groupOpen-labelTreatment
Summary
The overall aim of the study is to prospectively investigate the impact of two maintenance calcineurin inhibitor immunosuppressive regimens: once-daily extended release tacrolimus and twice-daily tacrolimus on subpopulations of T and B cells and alloreactive T cells as well as on renal allograft function.
Timeline
- Start
- 2017-09-05
- Primary completion
- 2021-02-23
- Completion
- 2021-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | — | — |
| Comparator | Tacrolimus | Small molecule | — | Oral |